DOI QR코드

DOI QR Code

High Preoperative Fibrinogen and Systemic Inflammation Response Index (F-SIRI) Predict Unfavorable Survival of Resectable Gastric Cancer Patients

  • Gao, Weiwei (Department of Oncology, The First Affiliated Hospital of Anhui Medical University) ;
  • Zhang, Fei (Department of Oncology, The First Affiliated Hospital of Anhui Medical University) ;
  • Ma, Tai (Department of Oncology, The First Affiliated Hospital of Anhui Medical University) ;
  • Hao, Jiqing (Department of Oncology, The First Affiliated Hospital of Anhui Medical University)
  • 투고 : 2019.09.19
  • 심사 : 2020.04.11
  • 발행 : 2020.06.30

초록

Purpose: This study was to investigate the prognostic significance of the preoperative fibrinogen and systemic inflammation response index (F-SIRI) in a Chinese cohort of resectable gastric cancer. Materials and Methods: Baseline characteristics, preoperative fibrinogen levels and peripheral neutrophil, monocyte, and lymphocyte counts were retrospectively reviewed in 240 patients who underwent radical gastrectomy. The optimal cut-off values for fibrinogen and SIRI were defined as 4.0 g/L and 1.2. Then patients with hyperfibrinogenemia (≥4.0 g/L) and high SIRI (≥1.2) were assigned with an F-SIRI of 2 (both of these hematological abnormalities), 1 (one of these abnormalities), and 0 (neither abnormality), respectively. The prognostic value was examined by univariate and multivariate survival analysis. Results: Preoperative F-SIRI was significantly correlated with tumor size, fibrinogen level, and adjuvant chemotherapy. Whereas there was no significant difference in age, gender, tumor location or other characteristics between groups. In addition, high preoperative F-SIRI was significantly associated with worse disease-free survival (DFS) (hazard ratio [HR], 2.299; 95% confidence interval [CI], 1.482-3.566; P<0.001) and overall survival (OS) (HR, 2.461; 95% CI, 1.584-3.824; P<0.001) by univariate survival analysis. Moreover, it remained an independent predictor for impaired DFS (HR, 2.023; 95% CI, 1.273-3.215; P=0.003) and OS (HR, 2.341; 95% CI, 1.480-3.705; P<0.001) in multivariate Cox regression analysis. Conclusions: Preoperative F-SIRI could serve as a significantly prognostic marker for long-term survival in Chinese patients who underwent radical gastrectomy.

키워드

참고문헌

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. https://doi.org/10.3322/caac.21262
  2. Thrumurthy SG, Chaudry MA, Hochhauser D, Mughal M. The diagnosis and management of gastric cancer. BMJ 2013;347:f6367. https://doi.org/10.1136/bmj.f6367
  3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-674. https://doi.org/10.1016/j.cell.2011.02.013
  4. Lee SE, Lee JH, Ryu KW, Nam BH, Cho SJ, Lee JY, et al. Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer. J Gastric Cancer 2012;12:81-87. https://doi.org/10.5230/jgc.2012.12.2.81
  5. Perisanidis C, Psyrri A, Cohen EE, Engelmann J, Heinze G, Perisanidis B, et al. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev 2015;41:960-970. https://doi.org/10.1016/j.ctrv.2015.10.002
  6. Yamashita H, Kitayama J, Nagawa H. Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer. Jpn J Clin Oncol 2005;35:595-600. https://doi.org/10.1093/jjco/hyi150
  7. Yamashita H, Kitayama J, Kanno N, Yatomi Y, Nagawa H. Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 2006;6:147. https://doi.org/10.1186/1471-2407-6-147
  8. Yu W, Wang Y, Shen B. An elevated preoperative plasma fibrinogen level is associated with poor overall survival in Chinese gastric cancer patients. Cancer Epidemiol 2016;42:39-45. https://doi.org/10.1016/j.canep.2016.03.004
  9. Yu X, Hu F, Yao Q, Li C, Zhang H, Xue Y. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer 2016;16:480. https://doi.org/10.1186/s12885-016-2510-z
  10. Suzuki T, Shimada H, Nanami T, Oshima Y, Yajima S, Ito M, et al. Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer. Surg Today 2016;46:1394-1401. https://doi.org/10.1007/s00595-016-1339-z
  11. Chang WJ, Du Y, Zhao X, Ma LY, Cao GW. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol 2014;20:4586-4596. https://doi.org/10.3748/wjg.v20.i16.4586
  12. Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY. A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Ther 2015;8:1375-1385.
  13. Wang K, Diao F, Ye Z, Zhang X, Zhai E, Ren H, et al. Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chin J Cancer 2017;36:75. https://doi.org/10.1186/s40880-017-0243-2
  14. Arigami T, Okumura H, Matsumoto M, Uchikado Y, Uenosono Y, Kita Y, et al. Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosis. Medicine (Baltimore) 2015;94:e1702. https://doi.org/10.1097/MD.0000000000001702
  15. Li S, Lan X, Gao H, Li Z, Chen L, Wang W, et al. Systemic inflammation response index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J Cancer Res Clin Oncol 2017;143:2455-2468. https://doi.org/10.1007/s00432-017-2506-3
  16. Wakatsuki K, Matsumoto S, Migita K, Ito M, Kunishige T, Nakade H, et al. Preoperative plasma fibrinogen is associated with lymph node metastasis and predicts prognosis in resectable esophageal cancer. World J Surg 2017;41:2068-2077. https://doi.org/10.1007/s00268-017-3991-x
  17. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol 2014;15:e493-e503. https://doi.org/10.1016/S1470-2045(14)70263-3
  18. Taniguchi K, Karin M. $NF-{\kappa}B$, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 2018;18:309-324. https://doi.org/10.1038/nri.2017.142
  19. Fest J, Ruiter R, Mulder M, Groot Koerkamp B, Ikram MA, Stricker BH, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study. Int J Cancer 2020;146:692-698. https://doi.org/10.1002/ijc.32303
  20. Palaj J, Keckes S, Marek V, Dyttert D, Waczulikova I, Durdik S. Fibrinogen levels are associated with lymph node involvement and overall survival in gastric cancer patients. Anticancer Res 2018;38:1097-1104.
  21. Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer 2016;122:2158-2167. https://doi.org/10.1002/cncr.30057
  22. Geng Y, Zhu D, Wu C, Wu J, Wang Q, Li R, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol 2018;65:503-510. https://doi.org/10.1016/j.intimp.2018.10.002
  23. Motoyama S, Miura M, Hinai Y, Maruyama K, Usami S, Saito H, et al. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer. Ann Surg Oncol 2009;16:2479-2485. https://doi.org/10.1245/s10434-009-0525-2

피인용 문헌

  1. Single-particle fibrinogen detection using platelet membrane-coated fluorescent polystyrene nanoparticles vol.13, pp.5, 2020, https://doi.org/10.1039/d0nr08492a
  2. Systemic Inflammation Response Index as a Prognostic Marker in Cancer Patients: A Systematic Review and Meta-Analysis of 38 Cohorts vol.19, pp.4, 2020, https://doi.org/10.1177/15593258211064744